Use of CCI-779 as an antineoplastic agent

Use of CCI-779 as an antineoplastic agent

  • CN 1,678,312 A
  • Filed: 11/13/2001
  • Published: 10/05/2005
  • Est. Priority Date: 11/15/2000
  • Status: Active Application
First Claim
Patent Images

1. treatment has the method for the tumor in the mammal that needs, and comprises the CCI-779 that offers this mammal effective dose.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×